Although renowned as a nociceptive receptor, TRPV1 expression has been detected in many cancers, including glioma [2], breast cancer [3], prostate cancer [4], colon adenocarcinoma [5], and pancreatic cancer [6]. The gene discussed is TRPV1; the disease is central nervous system cancer.